JPS62153228A - スクロ−スを含まない製剤 - Google Patents

スクロ−スを含まない製剤

Info

Publication number: JPS62153228A
Authority: JP; Japan
Prior art keywords: fructose; formulation; sweetener; usp; sucrose
Prior art date: 1985-12-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP29235885A

Other languages

English (en)

Japanese (ja)

Inventor

メアリアン・メンチ

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Warner Lambert Co LLC

Original Assignee

Warner Lambert Co LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-01-02

Filing date

1985-12-26

Publication date

1987-07-08

1985-12-26 Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC

1987-07-08 Publication of JPS62153228A publication Critical patent/JPS62153228A/ja

Status Pending legal-status Critical Current

Links

CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 title description 8
229930006000 Sucrose Natural products 0.000 title description 8
239000005720 sucrose Substances 0.000 title description 8
239000003814 drug Substances 0.000 title description 5
229940079593 drug Drugs 0.000 title description 4
239000000203 mixture Substances 0.000 claims description 35
239000005715 Fructose Substances 0.000 claims description 30
229930091371 Fructose Natural products 0.000 claims description 30
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 30
238000009472 formulation Methods 0.000 claims description 24
235000003599 food sweetener Nutrition 0.000 claims description 14
239000003765 sweetening agent Substances 0.000 claims description 14
206010012601 diabetes mellitus Diseases 0.000 claims description 9
239000004480 active ingredient Substances 0.000 claims description 5
238000000034 method Methods 0.000 claims description 5
208000024891 symptom Diseases 0.000 claims description 5
239000008194 pharmaceutical composition Substances 0.000 claims description 4
239000003434 antitussive agent Substances 0.000 claims description 3
229940124584 antitussives Drugs 0.000 claims description 3
239000003937 drug carrier Substances 0.000 claims description 2
230000002401 inhibitory effect Effects 0.000 claims 1
230000006362 insulin response pathway Effects 0.000 claims 1
206010011224 Cough Diseases 0.000 description 10
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
239000008103 glucose Substances 0.000 description 9
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
238000002360 preparation method Methods 0.000 description 5
239000008213 purified water Substances 0.000 description 5
239000001509 sodium citrate Substances 0.000 description 5
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 5
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
239000008280 blood Substances 0.000 description 4
210000004369 blood Anatomy 0.000 description 4
235000011187 glycerol Nutrition 0.000 description 4
230000004044 response Effects 0.000 description 4
102000004877 Insulin Human genes 0.000 description 3
108090001061 Insulin Proteins 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
239000013078 crystal Substances 0.000 description 3
229940125396 insulin Drugs 0.000 description 3
235000000346 sugar Nutrition 0.000 description 3
150000005846 sugar alcohols Chemical class 0.000 description 3
235000020357 syrup Nutrition 0.000 description 3
239000006188 syrup Substances 0.000 description 3
CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 2
JGKJMBOJWVAMIJ-UHFFFAOYSA-N 4-(2-hydroxypropan-2-yl)-1-methylcyclohexan-1-ol;hydrate Chemical compound O.CC(C)(O)C1CCC(C)(O)CC1 JGKJMBOJWVAMIJ-UHFFFAOYSA-N 0.000 description 2
108010011485 Aspartame Proteins 0.000 description 2
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
229930195725 Mannitol Natural products 0.000 description 2
240000008042 Zea mays Species 0.000 description 2
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
235000002017 Zea mays subsp mays Nutrition 0.000 description 2
239000013543 active substance Substances 0.000 description 2
235000019270 ammonium chloride Nutrition 0.000 description 2
229960004543 anhydrous citric acid Drugs 0.000 description 2
229940125715 antihistaminic agent Drugs 0.000 description 2
239000000739 antihistaminic agent Substances 0.000 description 2
239000000605 aspartame Substances 0.000 description 2
235000010357 aspartame Nutrition 0.000 description 2
IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
229960003438 aspartame Drugs 0.000 description 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
RBNWAMSGVWEHFP-UHFFFAOYSA-N cis-p-Menthan-1,8-diol Natural products CC(C)(O)C1CCC(C)(O)CC1 RBNWAMSGVWEHFP-UHFFFAOYSA-N 0.000 description 2
235000005822 corn Nutrition 0.000 description 2
229960000520 diphenhydramine Drugs 0.000 description 2
ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 2
229960000525 diphenhydramine hydrochloride Drugs 0.000 description 2
230000000694 effects Effects 0.000 description 2
239000003172 expectorant agent Substances 0.000 description 2
230000003419 expectorant effect Effects 0.000 description 2
201000001421 hyperglycemia Diseases 0.000 description 2
239000007788 liquid Substances 0.000 description 2
239000000594 mannitol Substances 0.000 description 2
235000010355 mannitol Nutrition 0.000 description 2
201000009240 nasopharyngitis Diseases 0.000 description 2
235000019204 saccharin Nutrition 0.000 description 2
CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
229940081974 saccharin Drugs 0.000 description 2
239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 2
239000007787 solid Substances 0.000 description 2
239000000243 solution Substances 0.000 description 2
239000000600 sorbitol Substances 0.000 description 2
235000010356 sorbitol Nutrition 0.000 description 2
239000000126 substance Substances 0.000 description 2
NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
WQNHWIYLCRZRLR-UHFFFAOYSA-N 2-(3-hydroxy-2,5-dioxooxolan-3-yl)acetic acid Chemical compound OC(=O)CC1(O)CC(=O)OC1=O WQNHWIYLCRZRLR-UHFFFAOYSA-N 0.000 description 1
QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 1
206010067484 Adverse reaction Diseases 0.000 description 1
CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
206010012735 Diarrhoea Diseases 0.000 description 1
206010013911 Dysgeusia Diseases 0.000 description 1
HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
206010019233 Headaches Diseases 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
206010052341 Impaired insulin secretion Diseases 0.000 description 1
CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
206010030113 Oedema Diseases 0.000 description 1
208000017442 Retinal disease Diseases 0.000 description 1
206010038923 Retinopathy Diseases 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
239000003929 acidic solution Substances 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000006838 adverse reaction Effects 0.000 description 1
230000007815 allergy Effects 0.000 description 1
229940024606 amino acid Drugs 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
230000000954 anitussive effect Effects 0.000 description 1
-1 antiallergens Substances 0.000 description 1
239000008122 artificial sweetener Substances 0.000 description 1
235000021311 artificial sweeteners Nutrition 0.000 description 1
229960005261 aspartic acid Drugs 0.000 description 1
230000000711 cancerogenic effect Effects 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
231100000315 carcinogenic Toxicity 0.000 description 1
239000000969 carrier Substances 0.000 description 1
229960004106 citric acid Drugs 0.000 description 1
235000009508 confectionery Nutrition 0.000 description 1
239000000850 decongestant Substances 0.000 description 1
229940124581 decongestants Drugs 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
235000020880 diabetic diet Nutrition 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000037213 diet Effects 0.000 description 1
RAUYIDQLJZIDDD-UHFFFAOYSA-N diphenyl-$l^{3}-chlorane Chemical compound C=1C=CC=CC=1[ClH]C1=CC=CC=C1 RAUYIDQLJZIDDD-UHFFFAOYSA-N 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
229940066493 expectorants Drugs 0.000 description 1
230000037406 food intake Effects 0.000 description 1
235000021433 fructose syrup Nutrition 0.000 description 1
230000002641 glycemic effect Effects 0.000 description 1
229960002146 guaifenesin Drugs 0.000 description 1
231100000869 headache Toxicity 0.000 description 1
235000019534 high fructose corn syrup Nutrition 0.000 description 1
230000000544 hyperemic effect Effects 0.000 description 1
230000003345 hyperglycaemic effect Effects 0.000 description 1
210000003016 hypothalamus Anatomy 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
239000008141 laxative Substances 0.000 description 1
229940125722 laxative agent Drugs 0.000 description 1
230000003902 lesion Effects 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
239000007937 lozenge Substances 0.000 description 1
229940041616 menthol Drugs 0.000 description 1
HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
230000000116 mitigating effect Effects 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
230000000291 postprandial effect Effects 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000025488 response to cold Effects 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
229910052814 silicon oxide Inorganic materials 0.000 description 1
206010041232 sneezing Diseases 0.000 description 1
WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
235000010234 sodium benzoate Nutrition 0.000 description 1
239000004299 sodium benzoate Substances 0.000 description 1
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
239000007909 solid dosage form Substances 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
235000019605 sweet taste sensations Nutrition 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
230000005748 tumor development Effects 0.000 description 1
239000003981 vehicle Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
150000003722 vitamin derivatives Chemical class 0.000 description 1
239000000811 xylitol Substances 0.000 description 1
235000010447 xylitol Nutrition 0.000 description 1
HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
229960002675 xylitol Drugs 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

JP29235885A 1986-01-02 1985-12-26 スクロ−スを含まない製剤 Pending JPS62153228A (ja)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
BE6/48177A BE903975A (fr)	1986-01-02	1986-01-02	Formulations exemptes de sucrose.

Publications (1)

Publication Number	Publication Date
JPS62153228A true JPS62153228A (ja)	1987-07-08

Family

ID=3874979

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP29235885A Pending JPS62153228A (ja)	1986-01-02	1985-12-26	スクロ−スを含まない製剤

Country Status (7)

Country	Link
JP (1)	JPS62153228A (fr)
AU (1)	AU5157885A (fr)
BE (1)	BE903975A (fr)
FR (1)	FR2592303A1 (fr)
GB (1)	GB2184352B (fr)
LU (1)	LU86237A1 (fr)
NL (1)	NL8503539A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2003526354A (ja) *	2000-03-14	2003-09-09	アボット・ラボラトリーズ	糖尿病患者の栄養剤

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5346887A (en) *	1976-10-12	1978-04-26	Okura Industrial Co Ltd	Method of shrinkage wrapping

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB948542A (en) *	1961-12-27	1964-02-05	Smith Brothers Inc	Improvements in or relating to pharmaceutical compositions
US3996355A (en) *	1975-01-02	1976-12-07	American Home Products Corporation	Permanent suspension pharmaceutical dosage form
US4210637A (en) *	1978-07-31	1980-07-01	Massachusetts Institute Of Technology	Composition and method for suppressing appetite for calories as carbohydrates
GB2064938A (en) *	1979-10-05	1981-06-24	Gawen P	Energy-providing drink suitable for diabetics
US4352821A (en) *	1981-07-21	1982-10-05	Shaklee Corporation	Sweet tableting agent
GB2118040A (en) *	1982-02-15	1983-10-26	Hoechst Uk Ltd	Oral anti-diabetic preparation
SE8203953D0 (sv) *	1982-06-24	1982-06-24	Astra Laekemedel Ab	Pharmaceutical mixture

1985
- 1985-12-20 NL NL8503539A patent/NL8503539A/nl not_active Application Discontinuation
- 1985-12-21 GB GB8531555A patent/GB2184352B/en not_active Expired - Fee Related
- 1985-12-23 AU AU51578/85A patent/AU5157885A/en not_active Abandoned
- 1985-12-26 JP JP29235885A patent/JPS62153228A/ja active Pending
- 1985-12-26 FR FR8519234A patent/FR2592303A1/fr active Pending
- 1985-12-30 LU LU86237A patent/LU86237A1/fr unknown
1986
- 1986-01-02 BE BE6/48177A patent/BE903975A/fr not_active IP Right Cessation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5346887A (en) *	1976-10-12	1978-04-26	Okura Industrial Co Ltd	Method of shrinkage wrapping

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2003526354A (ja) *	2000-03-14	2003-09-09	アボット・ラボラトリーズ	糖尿病患者の栄養剤

Also Published As

Publication number	Publication date
GB8531555D0 (en)	1986-02-05
GB2184352A (en)	1987-06-24
LU86237A1 (fr)	1986-04-14
AU5157885A (en)	1987-06-25
GB2184352B (en)	1990-05-09
FR2592303A1 (fr)	1987-07-03
NL8503539A (nl)	1987-07-16
BE903975A (fr)	1986-07-02

Publication	Publication Date	Title
EP2484352B1 (fr)	2014-07-09	Compositions liquides d'acétate de calcium
US20260021185A1 (en)	2026-01-22	Local anesthetic solution for dental and/or contrast media use
EP0405930A2 (fr)	1991-01-02	Suspension pharmaceutique aqueuse pour des agents actifs pharmaceutiques essentiellement insolubles dans l'eau
JP2012505172A (ja)	2012-03-01	パラセタモールを有する液体医薬製剤
US11202756B2 (en)	2021-12-21	Oral disintegrating film compositions of paracetamol
EP1067934B1 (fr)	2003-11-26	Solution orale liquide contenant l'antidepresseur mirtazapine
JP2013049722A (ja)	2013-03-14	ロキソプロフェン含有経口用組成物３
JP3805646B2 (ja)	2006-08-02	医薬液剤
JP6410814B2 (ja)	2018-10-24	フェキソフェナジンを含む経口投与用液体医薬組成物
McKENZIE et al.	1978	Serum theophylline levels in asthmatic children after oral administration of two slow-release theophylline preparations.
JPS62153228A (ja)	1987-07-08	スクロ−スを含まない製剤
US20110280941A1 (en)	2011-11-17	Compositions of proton pump inhibitors and insulin secretagogues, and methods of their use to treat diabetes
JP2003512315A (ja)	2003-04-02	粉末医薬製剤
JP2005139165A (ja)	2005-06-02	ロキソプロフェン含有経口用組成物
JPH09286723A (ja)	1997-11-04	改善された経口液剤
JPS63313725A (ja)	1988-12-21	シロツプ剤
Pedersen et al.	1986	Food and fasting absorption of a single dose of a sustained release theophylline sprinkle formulation in children
KR100617856B1 (ko)	2006-08-28	새로운 껌 타입의 시부트라민 제제 조성물
Morris	1940	The newer insulins
JPS6345371B2 (fr)	1988-09-09
JPS63313734A (ja)	1988-12-21	シロツプ剤
JPH03201970A (ja)	1991-09-03	イチョウ葉エキス含有シロップ
HK1032012B (en)	2004-03-19	Oral liquid solution comprising the antidepressant mirtazapine
HK1129814B (en)	2012-11-23	Liquid compositions of calcium acetate

JPS62153228A - スクロ−スを含まない製剤 - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (1)

Publications (1)

Family

ID=3874979

Family Applications (1)

Country Status (7)

Cited By (1)

Citations (1)

Family Cites Families (7)

Patent Citations (1)

Cited By (1)

Also Published As

Similar Documents